DDL 2024: Advancements in Drug Delivery to the Lungs Conference
Join us in Edinburgh, Scotland, December 11-13, 2024.
InPharmaTEC is excited to announce its participation in the Drug Delivery to the Lungs Conference (DDL) 2024.
The Drug Delivery to the Lungs Conference (DDL) is the premier conference and industry exhibition dedicated to pulmonary and nasal drug delivery, held every December in Edinburgh, Scotland. This year, the conference is in its 35th year and attracts over 1000 attendees from around the world, including scientists, academics, clinicians, regulators, and industry experts.
The event features a large industry exhibition, supported by more than 100 international companies, showcasing the latest advancements in drug delivery technology. Attendees can also explore a scientific poster hall that highlights cutting-edge research in the field. The conference program includes expert lectures from renowned speakers, covering topics such as novel formulation techniques, delivery devices, and regulatory challenges. Additionally, DDL provides excellent networking opportunities throughout the three-day event, fostering partnerships that drive innovation in pulmonary and nasal drug delivery.
Don’t miss this opportunity to connect with industry experts and explore the latest advancements in the field.
We warmly invite all attendees to visit InPharmaTEC at booth n 140 to learn more about our latest innovations and explore opportunities for collaboration.
Learn more about DDL:
https://ddl-conference.com/
